Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_2
1
50%
Ph phase_3
1
50%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
Phase 3Large-scale testing
1(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

2

all time

Status Distribution
Active(1)
Terminated(1)

Detailed Status

Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
0
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 21 (50.0%)
Phase 31 (50.0%)

Trials by Status

withdrawn150%
not_yet_recruiting150%

Recent Activity

0 active trials
Showing 2 of 2
not_yet_recruitingphase_3

Comparison of Curcumin and Intralesional Steroids in Oral Submucous Fibrosis

NCT06758739
withdrawnphase_2

Trial of Curcumin in Cutaneous T-cell Lymphoma Patients

NCT00969085

Clinical Trials (2)

Showing 2 of 2 trials
NCT06758739Phase 3

Comparison of Curcumin and Intralesional Steroids in Oral Submucous Fibrosis

Not Yet Recruiting
NCT00969085Phase 2

Trial of Curcumin in Cutaneous T-cell Lymphoma Patients

Withdrawn

All 2 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
2